Sentence examples for lowering trial from inspiring English sources

Two prospective studies demonstrate that increased homocysteine levels double the risk of fractures (van Meurs et al. 2004), which finds support in one homocysteine lowering trial in post-stroke patients (Sato et al. 2005).This single study needs further confirmation from additional trials.

This post-hoc analysis of the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial was designed to assess the comparative treatment efficacy of high-dose atorvastatin and usual-dose simvastatin for the prevention of events subsequent to the first event, using the Wei, Lin, and Weissfeld method.

At least one outcomes study looking into CV end points with exenatide once weekly is currently in progress (Exenatide Study of Cardiovascular Event Lowering Trial [EXSCEL], NCT01144338) and is estimated to be completed in March 2018.

The Exenatide Study of Cardiovascular Event Lowering Trial: A Randomized, Placebo-Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with ExQW in Patients with T2DM (EXSCEL, NCT01144338) will test major adverse cardiovascular outcomes including heart failure in 9,500 patients and is expected to announce the outcomes in April 2018.

Before starting the review we hypothesised that several features of trial design might affect the outcome of cholesterol lowering trials of statins.

Analyses from lipid and blood pressure lowering trials, which included only a small number of subjects with diabetes, showed somewhat lower annual progression rates (0.015 ± 0.053 mm) [ 21].

20 Short of further randomised trials, individual patient level data analysis of participants in all homocysteine lowering trials according to kidney disease status may increase analysis power providing greater clarity.

However, a meta-analysis of eight large homocysteine lowering trials completed before 2009 and involving 37 485 participants and 1528 first stroke events reported that lowering homocysteine concentrations had no beneficial effects on first stroke.

Although the underlying rationale for this (and other) blood pressure lowering trials was to lower hematoma expansion, this phase 3 trial, in contrast to the prior phase 2 trial, failed to show a significant effect of blood pressure reduction on such expansion [ 43, 44].

In New York most judges are elected, even to lower trial courts.

Though national statistics are not readily available, the trend toward lower trial rates is evident in a number of places.